TY  - JOUR
AU  - Morales-Garcia, Jose A
AU  - Gine, Elena
AU  - Hernandez-Encinas, Elena
AU  - Aguilar-Morante, Diana
AU  - Sierra-Magro, Ana
AU  - Sanz-SanCristobal, Marina
AU  - Alonso-Gil, Sandra
AU  - Sanchez-Lanzas, Raul
AU  - Castaño, Jose G
AU  - Santos, Angel
AU  - Perez-Castillo, Ana
PY  - 2017
DO  - 10.1038/s41598-017-13269-4
UR  - http://hdl.handle.net/10668/11703
T2  - Scientific reports
AB  - The CCAAT/Enhancer binding protein β (C/EBPβ) is a transcription factor involved in numerous physiological as well as pathological conditions in the brain. However, little is known regarding its possible role in neurodegenerative disorders. We have...
LA  - en
PB  - Nature Publishing Group
KW  - Neurology
KW  - Parkinson's disease
KW  - Animals
KW  - Apoptosis
KW  - CCAAT-Enhancer-Binding Protein-beta
KW  - Cells, Cultured
KW  - Disease Models, Animal
KW  - Dopaminergic Neurons
KW  - Humans
KW  - Male
KW  - Mesencephalon
KW  - Oxidopamine
KW  - Parkinson Disease
KW  - Pars Compacta
KW  - RNA Interference
KW  - RNA, Small Interfering
KW  - Rats
KW  - Rats, Wistar
KW  - alpha-Synuclein
TI  - CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson's disease.
TY  - research article
VL  - 7
ER  -